Zogenix Inc is engaged in developing and commercializing therapeutic solutions for people living with serious and life-threatening rare CNS disorders and medical conditions. Its product candidate includes ZX008, low-dose fenfluramine for the treatment of Dravet syndrome, LGS, and potentially other rare and catastrophic epilepsy disorders. If you want more trading...
ZGNX has broken the neckline level on this double top formation. I'm expecting a potential correction for one more wave down.
This stock has been driving people crazy but I think it is time to buy. FDA Approval and partnership looming.